We are live on ! Find out more
N

Natixis Portfolio holdings

AUM $28B
1-Year Est. Return 26.79%
 

Natixis is a global financial services business line of Groupe BPCE, offering a range of services including corporate and investment banking, asset management, insurance, and wealth management, with a focus on green and sustainable finance.

This Fund
S&P 500
This Quarter Est. Return
+9.92%
1 Year Est. Return
+26.79%
3 Year Est. Return
+97.72%
5 Year Est. Return
+108.83%
10 Year Est. Return
+452.99%
AUM
$29.3B
AUM Growth
+$364M
Cap. Flow
-$1.87B
Cap. Flow %
-6.38%
Top 10 Hldgs %
36.52%
Holding
1,426
New
244
Increased
439
Reduced
466
Closed
216

Sector Composition

Rank Sector Weight
1 Technology 22.85%
2 Consumer Discretionary 12.85%
3 Financials 8.79%
4 Communication Services 8.57%
5 Healthcare 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GEO icon
1176
The GEO Group
GEO
$4.13B
$155K ﹤0.01%
20,000
CVE icon
1177
Cenovus Energy
CVE
$54.6B
$150K ﹤0.01%
12,180
-7,691
-39% -$92.1K
AHT
1178
Ashford Hospitality Trust
AHT
$21M
$146K ﹤0.01%
1,416
-1,416
-50% -$177K
SGMO
1179
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$117K ﹤0.01%
15,598
-8,485
-35% -$73.7K
MOMO
1180
Hello Group
MOMO
$869M
$113K ﹤0.01%
12,653
-4,070
-24% -$46.6K
TK icon
1181
Teekay
TK
$975M
$109K ﹤0.01%
33,000
GRUB
1182
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$108K ﹤0.01%
+10,000
New +$134K
IVR icon
1183
Invesco Mortgage Capital
IVR
$776M
$101K ﹤0.01%
3,450
CCLD icon
1184
CareCloud
CCLD
$94.3M
$77K ﹤0.01%
+12,250
New +$86.8K
PEI
1185
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$76K ﹤0.01%
4,667
SRNE
1186
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$73K ﹤0.01%
+15,730
New +$97.7K
KGC icon
1187
Kinross Gold
KGC
$28.5B
$68K ﹤0.01%
11,721
-4
-0% -$24
OPK icon
1188
Opko Health
OPK
$921M
$67K ﹤0.01%
+14,000
New +$56.7K
BTG icon
1189
B2Gold
BTG
$5.16B
$63K ﹤0.01%
16,000
-9,779
-38% -$39.2K
OPTN
1190
DELISTED
OptiNose
OPTN
$57K ﹤0.01%
2,333
RNAC icon
1191
Cartesian Therapeutics
RNAC
$232M
$37K ﹤0.01%
377
ATHX
1192
DELISTED
Athersys, Inc. Common Stock
ATHX
$37K ﹤0.01%
1,400
XXII
1193
22nd Century Group
XXII
$1.47M
0
VCNX
1194
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$33K ﹤0.01%
152
ALNA
1195
DELISTED
Allena Pharmaceuticals
ALNA
$30K ﹤0.01%
50,000
TXMD icon
1196
TherapeuticsMD
TXMD
$23.8M
$28K ﹤0.01%
1,600
LITS
1197
Lite Strategy Inc
LITS
$33.6M
$27K ﹤0.01%
500
EPZM
1198
DELISTED
Epizyme, Inc
EPZM
$26K ﹤0.01%
10,400
OGI
1199
Organigram Holdings
OGI
$132M
$25K ﹤0.01%
+3,525
New +$29.9K
SNDL icon
1200
Sundial Growers
SNDL
$325M
$21K ﹤0.01%
+3,600
New +$23.6K

Similar funds

Natixis's Q4 2021 Portfolio in Review

As of Q4 2021, Natixis held 1,426 positions worth $29.3B, up 1.3% from $28.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Natixis withdrew a net $1.87B in Q4 2021, closing 216 positions and reducing 466 holdings. Its most notable exit was iShares Russell 2000 ETF, an estimated $186M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Natixis opened a new position in iShares 1-3 Year Treasury Bond ETF worth $67.3M.

  • Natixis's largest Q4 2021 buy was iShares 1-3 Year Treasury Bond ETF: 786,300 shares worth $67.3M.
  • Natixis added most to Meta Platforms (Facebook) in Q4 2021, an estimated $248M increase.
  • Natixis's biggest Q4 2021 reduction was Microsoft, cutting an estimated $838M.
  • Natixis fully exited iShares Russell 2000 ETF in Q4 2021, selling an estimated $186M.
  • Natixis's ten largest holdings make up 37% of its $29.3B portfolio in Q4 2021.
  • Natixis opened 244 new positions and closed 216 in Q4 2021.
  • Natixis's portfolio value rose 1.3% quarter-over-quarter to $29.3B.

Based on Natixis's 13F filing for Q4 2021, filed 14 Feb 2022.